Anesthetic Considerations for Patients Taking Glucagon

Semaglutide, more commonly known by the brand names Ozempic®, Rybelsus®, and Wegovy™ is a glucagon-like peptide-1 (GLP-1) agonist that has been used for several years in the management of type 2 diabetes mellitus (T2DM).

This review is intended to rationally compile the multifactorial cardiovascular effects of glucagon-like peptide-1 receptor agonists available for the treatment of patients with type 2 diabetes.
Anesthetic Considerations in Adult Patients on Glucagon

Anesthetic Considerations in Adult Patients on Glucagon-Like Peptide-1 Receptor Agonists: Gastrointestinal Focus Joshi, Girish P. MBBS, MD, FFARCSI Author Information
Patients taking glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic peptide receptor agonists should: continue these drugs before surgery; have full risk assessment and stratification; and receive peri-operative techniques that may mitigate risk of pulmonary aspiration before, during and after sedation or general ...

Perioperative management of patients taking glucagon
The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients . This document represents a multidisciplinary consensus statement led by the Society ...
Summary The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients .

Perioperative management of patients taking glucagon
Authors: Oprea AD et al. British Journal of Anaesthesia, volume 135, issue 1 , 2026 This multidisciplinary consensus statement from the Society for Perioperative Assessment and Quality Improvement (SPAQI) addresses the increasingly common perioperative challenge of managing patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs). With widespread use for diabetes mellitus, obesity ...
Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of ...

American Society of Anesthesiologists Consensus
American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi-society guidance GLP-1 document. Read more ...




Glucagon-like peptide-1 (GLP-1) agonists are very popular and useful medications for the treatment of type 2 diabetes mellitus and obesity. Potent gastric emptying delay is common with these medications, serving as a major contributor to the ...